Week 7: Gastroenterology (1) (GI bleeding and disorders) Flashcards
(42 cards)
taking a bowel habit history
- How often are they going to the toilet?
- Has this changed from their usual?
- Has the form changed?
- Are they waking overnight to open their bowels?
- Is there any blood in the motion?
- Do they have tenesmus?
- Do they have faecal urgency or incontinence?
- Do the motions flush away easily?
IBD treatment
- Steroids
- Topical (suppositories or enemas)
- Oral (prednisolone, or in small bowel disease, budesonide)
- IV (hydrocortisone 100mg qds)
- If steroids don’t work: rescue therapy=ciclosporin, biologics or surgery
- Immunosuppressant medication
- UC specifically: Mesalazine (5-ASAs)
- Maintain remission in UC
- No role in Crohns
- Crohns specifically: Azathioprine and biologics (UC not on mesalazine)
- UC specifically: Mesalazine (5-ASAs)
- Regular blood tests to monitor FBC, U and E and LFTRs
two main types of IBD and risk factors
Risk factors
- Age <30
- Whites highest risk
- Family history
- Cig smoking
- NSAIDs medication
Two main types
- Crohns
- Ulcerative colitis
crohns characters
- can affect anywhere from mouth to the anus
- skip lesions
- transmural inflammation
- fissuring ulcers
- lymphoid and neutrophil
- non-caseating granulomas
- increased incidence in smokers
ulcerative colitis character
- always affects the rectum and extends proximally varying distances
- continous
- mucosal and sub mucosal inflammation only
- crypt abscesses
- decreased incidence in smokers
investigations for IBD
- Blood tests
- FBC- anaemia/ raised platelet count
- U and E- deranged electrolytes due to AKI due to GI losses
- CRP
- Stool tests
- Stool cultures- exclude infective colitis
- Faecal calprotectin- raised in active disease and negative in irritable bowel or IBD in remission, but not specific to IBD and shouldn’t be used if blood is present as the presence of blood requires further investigation
- Simple imaging
- AXR
- Used less commonly but used if suspicion of toxic megacolon and can be useful to assess for proximal constipation
- AXR
- Endoscopy
- Flexible sigmoidoscopy- safest test in bloody diarrhoea
- Colonoscopy- needed to look for more proximal disease
- Capsule endoscopy- useful to view small bowel mucosa
- Cross sectional imaging
- Acute complications
- MRI enterography when looking for small bowel crohns, fistulas or to map the extent of small bowel crohns
- MRI rectum is image perianal crohns
crohns disease presentation
- Diarrheal – non bloody
- Smoker
- Mildly anaemic
- Low grade fever
- Any inflammations stops us absorbing things diarrhoea weight loss
- Osmotic pressure drawing water out into the lumen
- Crohns unlikely to have bleeding
- Deeper but less widespread
- Tender mass RLQ
- Terminal ileum common site
- Low grade fever arthritis?
- Mild perianal inflammation fistulas and strictures
crohns presentation in the bowel
- Diarrheal – non bloody
- Smoker
- Mildly anaemic
- Low grade fever
- Any inflammations stops us absorbing things diarrhoea weight loss
- Osmotic pressure drawing water out into the lumen
- Crohns unlikely to have bleeding
- Deeper but less widespread
- Tender mass RLQ
- Terminal ileum common site
- Low grade fever arthritis?
- Mild perianal inflammation fistulas and strictures
ulcerative colitits presentation
Ulcerative colitis presentation
- Inflammatory bowel disease characterised by diffuse inflammation of the colonic mucosa*
- It affects the rectum and extends proximally : distal (proctitis), left sided (splenic flexure) and extensive (beyond splenic flexure)*
- Can be up to 40 bloody stools a day
- Blood and mucous= affecting mucosa
- Weight loss inflammation uses a lot of calories and diarrhoea can make you lose appetite
- Mild lower abdominal pain
- Normal temp
- Painful red eye extraintestinal problem
- Nocturnal symptoms
- Urgency
- tenesmus
ulcerative colitits presentation in the bowel
- Chronic inflammatory infiltrate of lamina propria
- Crypt abscesses (Neutrophilic exudate in crypts)
- Crypt distortion (bottom image)
- Irregular shaped gland with dysplasia
- Darker crowded nuclei
- Reduced numbers of goblet cells
- Pseudo polyps can develop after repeated episodes
- Inflammation then healing
- Nonneoplastic
- More common in UC ( vs Crohns)
- Loss of haustra
- Inflammation reduces the appeared of haustra on imaging
Endocscopy of IBD
X-ray of UC
- Left colon looks featureless
- Thumbprinting
- Mucosal oedema – should not be able to see lining of the bowel
extraintestinal. manifestations of IBD
erythema nodosum
apthous ulcers
acute arthropathy- sore joints
anteiro uveitis
ankylosing sponylittis
primary sclerosing cholangitis
aim of treating UC
- Induce remission in acute disease
- Maintain remission
- Improve quality of life
- Decrease risk of colo-rectal cancer
main drugs in treatment of UC
- anticoagulation
- steroids
- DMARDs
- mesalazine
- azathioprine
- ciclosporin
- biologics
- laxatives
anti-coagulation in treatment of UC
- IBD flare lead to prothrombotic state
- Need low molecular weight heparin – prevent micro-vascular occlusion e.g. DVT and PE
steroids in treatment of UC
- Induce remission
- Use topically (suppositories and enemas), orally or intravenously
- Remember bone protection
- 40mg prednisolone for 2 weeks followed by weaning of 5mg/week
mesalazine in treatment of UC
5-ASA
- Mesalazine is rapidly absorbed from the jejunum and so the drug has to be delivered to the colonic mucosa in one of several ways.
- Topical preparations can be applied PR
- Oral preparations can have various pharmacological modifications.
- pH sensitive resin or membranes can be used (Pentasa, Asacol)
- linking to another molecule that is enzymatically cleaved in the colon (Olsalazine, Sulphasalazine)
- Main role is in maintenance of remission, but can escalate dose to treat mild flares (decrease relapse rate by 2/3 compared with placebo)
- Decrease the risk of colo-rectal cancer (75% decreased risk quoted)
- Uncommon side effects include diarrhoea, headache, nausea & rash. Interstitial nephritis & nephritic syndrome are rare occurrences.
azathiprine in treatment of UC
- Steroid sparing agents that are used in patients intolerant of corticosteroids, in those who require ≥2 course of steroids per year, relapse once dose of Prednisolone is less than 15mg/day or if the disease relapses within 6 weeks of stopping steroids.
- Onset of action takes at least 6 weeks.
- Adverse reactions include flu like symptoms, GI upset, Leucopenia, Hepatitis, Pancreatitis, Rash & Infections
- Require monitoring of blood tests & use of sun block
- Seems to be effecting and safe in the long term.
- Mercaptopurine is the active metabolite of Azathioprine & is often tolerated by those who cannot tolerate Azathioprine.
ciclosporin in treatment of UC
- Calcineurin inhibitor
- Used as salvage therapy in patients with severe refractory colitis
- Has a rapid onset of action (initially IV then PO)
- Short-term it decreases colectomy rate by about 50%, but its use is limited due to toxicity and long term failure rate.
- Main role is bridging to Azathioprine
biologics in treatment of UC
- Effective
- Newer drug in UC
- Acute UC if ciclosporin is contraindicated
- Maintenance treatment in moderate colitis if failed other therapies
- Infliximab
- Biosimilars
- Humira
- Gololumimab
- Vedoluzamab
laxatives in treatment of UC
- Colonic motility is affected by inflammation with rapid transit occurring through the inflamed colon
- In left sided disease the distal transit is rapid but proximal transit is slowed which can result in proximal constipation
- Relief of this proximal constipation may induce remission in left sided disease
surgery in UC
- Surgery involves near total colectomy with formation of an ileostomy. This stoma may be permanent, or particularly in younger patients can be rejoined with pouch surgery at a later date.
- There are a number of criteria that can predict the likelihood of colectomy being needed acutely (% with these criteria that require colectomy are in brackets):
- Predicting Colectomy:
-
Clinical & Biochemical:
- >12 stools/day on day 2 (55%)
- >8/day on day 3 of intensive Rx (85%)
- 3-8/day & CRP >45 on day 3 (85%)
- >4/day & CRP >25 on day 3 (75%)
- Albumin <33 before day 4 (55%)
-
Radiological:
- Colonic dilation >5.5cm (55% colectomy)
- Mucosal islands on plain AXR (85%)
- 3 or more small bowel loops (5-73%)
-
Clinical & Biochemical:
- Predicting Colectomy:
risk factor of coeliac disease
family hisotry